Real-time, in vivo rodent imaging, allows researchers to observe and monitor several normal and abnormal biological processes. Data collected using the eyes series, provides crucial initial insights and generate quantitative results that, in combination with the Visual | eyes interface, compose an essential platform for every preclinical laboratory.
Oncology
Non-invasively assess your agent's targeting properties, real-time monitor drug delivery and track tumor progression.
Infection, Inflammation
Acquire detailed insights into disease mechanisms, enhance more accurate diagnostics while supporting the development or improvement of new or already existing therapeutics.
Protocol optimization
Test different animal preparation conditions, drug concentrations and administration routes to optimize your protocols.
Quick insights
Scan the same mouse at multiple time points to determine the optimal moments for 3D imaging. Conduct super-fast QC to exclude faulty injected subjects from further and more complex studies.
Applications with eyes™
Oncology, Alpha Emitters
[225]Ac imaging using the γ-eye™
In vivo imaging of alpha-emitting isotopes made possible, with BIOEMTECH technology. Two illustrative images, from two timepoints: 2h and 24h post injection with a Ac-225 radiopharmaceutical, in an oncology model. Image info: Scan duration 10 min. Dose injected: 3.5 uCi / 0.13 Mbq. Images acquired at Radiomedix laboratories.
[177]Lu imaging using the γ-eye™
In vivo imaging of Lu-177 on a model with nanoparticles targeting bones. Image info: 24 h post injection acquisition, 20 min static scan. Total injected dose is 540 μCi / 19,98 MBq.
Oncology
[111]In-Dotatate imaging using the γ-eye™
The objective of this study was to assess the efficacy of 111In-Dotatate in targeting tumors, with and without the additional use of tumor protection. The images were acquired 3 hours post-injection, with a 6 min static scan. The total injected dose was 108 µCi /3.99 MBq.